Polysaccharides as Nanomaterials for Therapeutics - Harnessing Biomaterials in Nanomedicine: Preparation, Toxicity, and Applications - page 159

114. Lemarchand C, Couvreur P, Besnard M, Costantini D, Gref R (2003)
Novel polyester-polysaccharide nanoparticles. Pharm Res 20: 1284-
1292.
115. Choi KC, Bang JY, Kim C, Kim PI, Lee SR, et al. (2009) Antitumor eff ect
of adriamycin-encapsulated nanoparticles of poly(DL-lactide-co-
glycolide)-grafted dextran. J Pharm Sci 98: 2104-2112.
116. Bisht S, Maitra A (2009) Dextran-doxorubicin/chitosan
nanoparticles for solid tumor therapy. Wiley Interdiscip Rev
Nanomed Nanobiotechnol 1: 415-425.
117. Hornig S, Bunjes H, Heinze T (2009) Preparation and characterization
of nanoparticles based on dextran-drug conjugates. J Colloid Interface
Sci 338: 56-62.
118. Huang M, Vitharana SN, Peek LJ, Coop T, Berkland C (2007)
Polyelectrolyte complexes stabilize and controllably release vascular
endothelial growth factor. Biomacromolecules 8: 1607-1614.
119. Huang M, Berkland C (2009) Controlled release of repifermin from
polyelectrolyte complexes stimulates endothelial cell proliferation. J
Pharm Sci 98: 268-280.
120. Tiyaboonchai W, Woiszwillo J, Middaugh CR (2001) Formulation and
characterization of amphotericin B-polyethylenimine-dextran sulfate
nanoparticles. J Pharm Sci 90: 902-914.
121. Memisoglu-Bilensoy E, Vural I, Bochot A, Renoir JM, Duchene D, et
al. (2005) Tamoxifen citrate loaded amphiphilic beta-cyclodextrin
nanoparticles: in vitro characterization and cytotoxicity. J Control
Release 104: 489-496.
122. Davis ME (2009) The first targeted delivery of siRNA in humans via
a self-assembling, cyclodextrin polymer-based nanoparticle: from
concept to clinic. Mol Pharm 6: 659-668.
123. Choisnard L, Geze A, Putaux JL, Wong YS, Wouessidjewe D (2006)
Nanoparticles of beta-cyclodextrin esters obtained by self-assembling of
biotransesterified beta-cyclodextrins. Biomacromolecules 7: 515-520.
124. Spinner NB, Gibas Z, Kline R, Berger B, Jackson L (1992) Placental
mosaicism in a case of 46,XY,-22,+t(22;22)(p11;q11) or i(22q)
diagnosed at amniocentesis. Prenat Diagn 12: 47-51.
125. Davis ME, Zuckerman JE, Choi CH, Seligson D, Tolcher A, et al. (2010)
Evidence of RNAi in humans from systemically administered siRNA via
targeted nanoparticles. Nature 464: 1067-1070.
126. Elgart A, Farber S, Domb AJ, Polacheck I, Hoff man A (2010)
Polysaccharide pharmacokinetics: amphotericin B arabinogalactan
conjugate — a drug delivery system or a new pharmaceutical entity?
Biomacromolecules 11: 1972-1977.